Joseph Kado
The Kids Research Institute Australia, WA, Australia
- This delegate is presenting an abstract at this event.
Dr Kado is an i-Taukei Fijian paediatrician/cardiology-lead, child health, Strep A and RHD researcher. He helped to establish and lead the Fiji RHD Prevention & Control Program from 2007 to 2017. He continues to serve as a technical advisor to the Fiji program. Joe’s doctoral thesis explored novel uses of long-acting penicillins to improve secondary prophylaxis of RHD and introduced new ways of delivering long-acting penicillins. He is currently the Program Director for the Vaka Mauri Collective (formerly the Pacific RHD Program).
Presentations this author is a contributor to:
Population pharmacokinetics of penicillin G: insights into increased clearance at low concentrations to guide development of improved long-acting formulations for syphilis and prevention of rheumatic fever (#135)
5:30 PM
Laurens Manning
Poster Session 1
A randomised, double-blinded, placebo-controlled human challenge trial to establish the lowest penicillin concentration to prevent Streptococcus pyogenes pharyngitis (CHIPS). (118511)
9:39 AM
Laurens Manning
Plenary 5 - Interventions for Prevention
Evaluation of clinical decision rules for diagnosis of Streptococcus pyogenes pharyngitis in a tropical setting (119034)
12:20 PM
John Hart
Plenary 6 - Lessons From Niches of Stress, Vulnerability, and Resilience